Skip to content
AwardedPRTGoods

Ustecinumab 130 mg/26 ml sol inj fr 26 ml IV e Ustecinumab 90 mg/1 ml sol inj caneta 1 ml SC

Published
Published 17 July 2026

Overview

41005326 - Ustecinumab 130 mg/26 ml sol inj fr 26 ml IV e Ustecinumab 90 mg/1 ml sol inj caneta 1 ml SC

Key details

Country
PRT
Status
Awarded
Category
Goods
Published
17 July 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€953,414
Award date
19 March 2026
Winner
  • Janssen Cilag Farmacêutica, Lda

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    17 July 2026

Contracting authority

  • Unidade Local de Saúde de São José, EPE

    Procuring entity

    Lisboa, PRT

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Ustecinumab 130 mg/26 ml sol inj fr 26 ml IV e Ustecinumab 90 mg/1 ml sol inj caneta 1 ml SC — won by Janssen Cilag Farmacêutica, Lda — Skim